8-KLeadership ChangesExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Executive Changes (Oct 28, 2022)

Filed October 28, 2022For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on October 28, 2022, to disclose significant changes to the compensation package for Mr. Davis upon his promotion to Chief Executive Officer and President, effective November 1, 2022. These changes reflect his expanded responsibilities and aim to align his incentives with the company's performance and long-term value creation. The updated compensation includes a substantial increase in base salary, a higher target for annual incentives, and revised severance plan participation. Additionally, Mr. Davis will receive enhanced benefits such as transportation allowances and relocation assistance. A significant equity grant valued at $5,000,000, comprised of performance shares and restricted stock units, underscores the company's commitment to retaining and motivating its new CEO.

Key Highlights

  • 1Mr. Davis's base salary increased to $1,100,000 annually, effective November 1, 2022.
  • 2Target annual incentive increased to 150% of base salary, with pro-rata adjustments for 2022.
  • 3Mr. Davis moved to Schedule A Participant status in the Executive Officer Severance Plan.
  • 4New benefits include a transportation allowance up to $175,000 annually and relocation benefits up to $125,000.
  • 5A $5,000,000 equity grant was awarded, consisting of 60% performance shares and 40% restricted stock units.
  • 6Share ownership guidelines for Mr. Davis increased from four to six times his annual base salary.
  • 7The equity grant has performance goals aligned with other senior executives and specific vesting schedules for RSUs and performance shares.

Frequently Asked Questions

Upon his promotion to CEO, Mr. Davis's base salary increased to $1,100,000, his target annual incentive rose to 150% of base salary, and he received a $5,000,000 equity grant. Other significant changes include enhanced benefits like transportation and relocation assistance, a higher share ownership guideline, and a shift in his severance plan participation.

The $5,000,000 equity grant is composed of 60% performance shares and 40% restricted stock units (RSUs). The RSUs will vest on the third anniversary of the grant date. The performance shares will vest on February 24, 2025, contingent upon continued service and the achievement of performance goals consistent with those granted to other senior executives in February 2022.

The increased salary, target incentive, and substantial equity grant directly reflect the elevated responsibilities and expected contributions of the Chief Executive Officer. The inclusion of benefits like a transportation allowance and relocation assistance are standard executive perquisites for such a senior leadership position.

Yes, the compensation is contingent on Mr. Davis's continued service and, for the performance shares, the achievement of specific performance goals set by the company. His relocation benefits also have a defined maximum amount and usage period. The equity grant does not provide for accelerated vesting upon qualifying retirement.